(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. Loss of function of Dlx1/Dlx2 results in a loss of late-born RGCs
in the developing retina. (A,B) Expression of BRN3b in 7-day-old explant
cultures of wild-type and Dlx1/Dlx2 mutant retinas collected at
E18.5. BRN3b immunoreactivity is detected in wild type (A, box, insert) but
not in mutant explant cultures. (C-T) BrdU birthdating assays identify retinal
cells generated at the time of pulsing. (C-E,L-N) BrdU pulses at E12.5 label
RGCs as identified by BRN3b protein expression in mutant (C, arrows) and
wild-type (L, arrows) retinas collected at E18.5. (F-H,O-Q) E13.5 BrdU pulses
also readily identify RGCs in both mutant (F, arrows) and wild-type (O,
arrows) retinas. (I-K,R-T) BrdU pulses at E16.5 in mutant and wild-type
retinas. Co-expression with BRN3b can be seen only in the wild-type retina (R,
arrow). (U) Quantification of BRN3b-expressing RGCs born at E12.5, 13.5 and
16.5. RGCs born at E12.5 (asterisk) represent 10% of RGCs labeled in E18.5
wild-type retinas, but 16% of the RGCs in Dlx1/Dlx2 mutants yielding
a significantly larger proportion of the population at E18.5 (t=8.8,
P<0.05, n=5). RGCs born at E13.5 (cross) form a
significantly larger proportion of the population of RGCs in wild-type retinas
compared with mutants (15 versus 13.3%; t=3.32, P<0.05,
n=5). RGCs born at E16.5 (#) form a significantly larger proportion
(
3 fold) of the population of wild-type retinas than mutant retinas (1.5
versus 0.6% of E18.5 population; t=4.85, P<0.05,
n=5).